)
AVITA Medical (RCEL) investor relations material
AVITA Medical KOL event summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Introduction and agenda
Webinar and presentations focused on PermeaDerm clinical study results, real-world surgeon experiences, and economic and clinical outcomes as an alternative to allograft for wound temporization and closure.
Agenda included clinical trial data review, study design, product positioning, workflow analysis, economic impact, case studies, and Q&A with burn surgeons.
KOL background and credentials
Dr. Anju Saraswat: Assistant Professor of Surgery, Wake Forest University, and Burn Center Director at Atrium Health Wake Forest Baptist.
Dr. Christina Sharon: Burn and acute care surgeon, Burn Director at Baton Rouge General, Louisiana.
Panel included a Senior VP of Scientific & Medical Affairs and other experienced burn surgeons from major burn centers.
Market insights and analysis
PermeaDerm is positioned as a modern, synthetic alternative to cadaveric allograft, addressing supply, storage, disease transmission, and workflow limitations.
Surgeons highlighted ease of use, supply reliability, and workflow simplification as key advantages.
PermeaDerm is an off-the-shelf product, providing logistical and workflow benefits for hospitals.
- 2026 guidance raised to $86–$89M, with Q4 breakeven targeted and strong Q2 revenue growth.RCEL
Investor update - Revenue growth, margin stability, and product adoption drive confidence in sustained expansion.RCEL
Canaccord Genuity's 46th Annual Growth Conference - Q2 2026 revenue up 18% year-over-year; guidance raised, but going concern risk remains.RCEL
Q2 2026 - Sequential revenue growth, strong margins, and reaffirmed guidance signal renewed momentum.RCEL
Status update - Revenue up 4% to $19.3M, net loss narrows, but going concern risk remains.RCEL
Q1 2026 - Shareholders will vote on director elections, compensation, equity grants, and key capital changes.RCEL
Proxy filing - Cohealyx reduces grafting time and drives high surgeon satisfaction, supporting broader adoption.RCEL
KOL event - 2026 guidance targets $80–$85M revenue, with growth, reimbursement clarity, and new financing.RCEL
Status update - Q2 2024 revenue up as much as 44% to $19.5M; 2024 guidance set at $68–$70M.RCEL
Q2 2024
Next AVITA Medical earnings date
Next AVITA Medical earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage